Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Utilization of Genomic Biomarkers for Post-marketing Safety of Drugs]Nahoko Kaniwa
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 8, 2011
[Exploratory study on biomarkers associated with severe cutaneous adverse reactions]Nahoko Kaniwa
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|March 24, 2010
[Exploratory studies on genetic biomarkers related to serious drug adverse reactions]Nahoko Kaniwa, Ryuichi Hasegawa
Journal of Human Genetics|May 3, 2013
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injuryNahoko Kaniwa, Yoshiro Saito
Drug Metabolism and Pharmacokinetics|May 13, 2010
Prediction of severe adverse drug reactions using pharmacogenetic biomarkersMasahiro Tohkin, Akihiro Ishiguro, Nahoko Kaniwa, et al.
Pharmacogenetics and Genomics|November 15, 2013
Genetic factors associated with gemcitabine pharmacokinetics, disposition, and toxicityJonathan Knights, Yasunori Sato, Nahoko Kaniwa, et al.
Diabetes Research and Clinical Practice|December 6, 2005
Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetesKazuko Suzuki, Tatsuo Yanagawa, Toshiaki Shibasaki, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|January 21, 2012
[Current movements of four serious adverse events induced by medicinal drugs based on spontaneous reports in Japan]Chie Sudo, Yu-ichiro Azuma, Keiko Maekawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 3, 2013
[Biomarker exploration and its clinical use]Yoshiro Saito, Kimie Sai, Nahoko Kaniwa, et al.
Pageof 7